Giraudo Bryan insider trades
Giraudo Bryan has filed 25 Form 4s with the SEC that we hold, for Gossamer Bio, Inc. (GOSS) (COO/CFO) and Protagonist Therapeutics, Inc (PTGX) (Director). Across all of them we count 5 purchases worth $375.6K and 6 sales worth $6.0M reported on Form 4. In the last 12 months: 0 purchases ($0) and 4 sales ($5.9M). The largest single trade was a sale of 36,000 shares of Protagonist Therapeutics, Inc worth $3.6M, dated 2026-05-07. The first filing on our record is dated 2021-09-20 and the latest 2026-08-26.
Gossamer Bio, Inc. (GOSS)
COO/CFO · 19 filings · 7 purchases and sales
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2022-03-23 | S, sale reported on Form 4 | 10,722 | $95.6K | 2022-03-24 | SEC |
| 2022-07-15 | P, purchase reported on Form 4 | 13,869 | $100.0K | 2022-07-15 | SEC |
| 2023-03-20 | P, purchase reported on Form 4 | 50,000 | $48.5K | 2023-03-22 | SEC |
| 2023-04-04 | P, purchase reported on Form 4 | 55,000 | $56.1K | 2023-04-05 | SEC |
| 2023-11-13 | P, purchase reported on Form 4 | 200,000 | $112.0K | 2023-11-14 | SEC |
| 2024-03-27 | S, sale reported on Form 4 | 6,430 | $7.5K | 2024-03-28 | SEC |
| 2024-06-18 | P, purchase reported on Form 4 | 100,000 | $59.0K | 2024-06-20 | SEC |
Protagonist Therapeutics, Inc (PTGX)
Director · 6 filings · 4 purchases and sales
Source
Counted from the Form 4 filings this reporting owner (SEC CIK 1740847) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
